Lipitor MDL Approved for Type 2 Diabetes Litigation: McSweeney /...
Federal litigation involving Pfizer's cholesterol-lowering drug Lipitor has been consolidated before a single judge in South Carolina.(PRWeb March 25, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11664980.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 26, 2014 Category: Pharmaceuticals Source Type: news

Statins aren't a wonder drug | Malcolm Kendrick
The claims made for statins are overblown. They are not a cure for most of the major diseases afflicting western civilisationStatins are the most widely prescribed drugs in medical history. They appear to have effortlessly conquered heart disease. If guidance proposed by Nice – the National Institute for Health and Care Excellence – is followed, 15 million people in the UK, most with no history of heart disease, could soon be taking them.A recent study by researchers at Imperial College London made the claim that "statins have virtually no side effects, with users experiencing fewer adverse symptoms than if they had ta...
Source: Guardian Unlimited Science - March 23, 2014 Category: Science Authors: Malcolm Kendrick Tags: Comment The Guardian World news Health Health policy Society Drugs UK news Statins Comment is free Source Type: news

Statins aren't a wonder drug | Malcolm Kendrick
This article was corrected on 24 March 2014. It originally said in the eighth paragraph: "Flecainide suppressed dangerous heart arrhythmias, but was pulled from the market for killing thousands of people." This has been amended, as the drug that was pulled from the market was encainide, not flecainide.StatinsDrugsHealthHealth policyMalcolm Kendricktheguardian.com © 2014 Guardian News and Media Limited or its affiliated companies. All rights reserved. | Use of this content is subject to our Terms & Conditions | More Feeds (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 23, 2014 Category: Science Authors: Malcolm Kendrick Tags: Statins Drugs Health Health policy Society UK news World news The Guardian Comment Comment is free Source Type: news

New statin guidelines would put half of U.S. adults on drugs
Guidelines have been criticized for overreach by suggesting medications such as Zocor and Lipitor for such a broad swath of U.S. population (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 19, 2014 Category: Consumer Health News Source Type: news

Alonso Krangle Applauds the Judicial Panel’s Creation of Lipitor MDL...
The United States Judicial Panel (USJP) on Multidistrict Litigation (MDL) has recently issued a transfer order that will remit 56 Lipitor lawsuits and many more tag-along actions to the District of...(PRWeb March 18, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11678193.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 18, 2014 Category: Pharmaceuticals Source Type: news

Generic atorvastatin recall applies to 90-count bottles of 10-mg tablets
Read the full story on MD Consult: Generic atorvastatin recall applies to 90-count bottles of 10-mg tablets (Source: MD Consult: News: Top Stories)
Source: MD Consult: News: Top Stories - March 13, 2014 Category: Journals (General) Source Type: news

Lipitor Lawsuits Consolidated in South Carolina Federal Court for...
Court Documents Indicate 68 Lipitor Diabetes Claims Are Now Pending in New Multidistrict Litigation, Additional Lipitor Lawsuits Expected to Be Transferred to South Carolina(PRWeb March 11, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11655530.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 11, 2014 Category: Pharmaceuticals Source Type: news

Over 64 000 Bottles of Ranbaxy's Generic Lipitor RecalledOver 64 000 Bottles of Ranbaxy's Generic Lipitor Recalled
The second recall of generic atorvastatin by the Indian drug maker comes after a pharmacist found a 10-mg-dose bottle to contain a 20-mg pill. News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 10, 2014 Category: Cardiology Tags: Cardiology News Alert Source Type: news

More India-made generic Lipitor recalled
Recall is latest in series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the U.S., its biggest market. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 10, 2014 Category: Consumer Health News Source Type: news

Generic Lipitor Recalled Again (FREE)
By the Editors Ranbaxy has recalled over 60,000 bottles of generic atorvastatin after … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 10, 2014 Category: Primary Care Source Type: news

Ranbaxy recalls some batches of generic Lipitor in latest quality blow
MUMBAI (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd, reeling under a flurry of regulatory rebukes due to poor quality, has recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States after doseage mix-up was detected. (Source: Reuters: Health)
Source: Reuters: Health - March 8, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

Ranbaxy Laboratories recalls over 64,000 bottles of generic Lipitor in US
Ranbaxy has recalled more than 64,000 bottles of generic Lipitor in the US due to reports of a dose mix-up, US regulators said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 8, 2014 Category: Pharmaceuticals Source Type: news

Ranbaxy recalls over 64,000 bottles of generic Lipitor in U.S
(Reuters) - Indian drug maker Ranbaxy Laboratories Ltd has recalled more than 64,000 bottles of the generic versions of its cholesterol-lowering drug in the United States due to reports of a dose mix-up, U.S. regulators said. (Source: Reuters: Health)
Source: Reuters: Health - March 8, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

Ranbaxy Recalls Generic Lipitor in U.S.
Ranbaxy Laboratories, the India-based generic-drug maker beset by manufacturing-quality problems, has issued another recall of generic versions of the cholesterol drug Lipitor in the U.S. because of a potential dose mix-up. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 8, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news

Lipitor Without a Rx? Pfizer Pushes Ahead With OTC PlansLipitor Without a Rx? Pfizer Pushes Ahead With OTC Plans
Pfizer has launched a 1200-patient study to investigate whether patients could successfully take OTC Lipitor. Patients would make treatment decisions once they obtained their own blood tests. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 4, 2014 Category: Consumer Health News Tags: Cardiology News Source Type: news